News Image

Why NYSE:DOCS Is a Standout High-Growth Stock in a Consolidation Phase.

By Mill Chart

Last update: Oct 24, 2023

Growth investors are on the lookout for stocks displaying robust revenue and EPS growth. In this analysis, we'll assess whether DOXIMITY INC-CLASS A (NYSE:DOCS) aligns with growth investing criteria, especially as it consolidates and signals a possible breakout. As always, investors should conduct their own research, but DOXIMITY INC-CLASS A has surfaced on our radar for growth with base formation, warranting further examination.

How We Gauge Growth for NYSE:DOCS

Every stock receives a Growth Rating from ChartMill, ranging from 0 to 10. This rating assesses various growth aspects, including historical and projected EPS and revenue growth. NYSE:DOCS boasts a 8 out of 10:

  • DOCS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 105.66% yearly.
  • DOCS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 53.27% yearly.
  • Based on estimates for the next years, DOCS will show a very strong growth in Earnings Per Share. The EPS will grow by 24.26% on average per year.
  • Based on estimates for the next years, DOCS will show a very strong growth in Revenue. The Revenue will grow by 21.10% on average per year.

A Closer Look at Health for NYSE:DOCS

A critical element of ChartMill's stock evaluation is the Health Rating, which spans from 0 to 10. This rating considers multiple health factors, including liquidity and solvency, both in absolute terms and relative to industry peers. NYSE:DOCS has received a 9 out of 10:

  • DOCS has an Altman-Z score of 17.86. This indicates that DOCS is financially healthy and has little risk of bankruptcy at the moment.
  • DOCS has a better Altman-Z score (17.86) than 95.35% of its industry peers.
  • DOCS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
  • A Current Ratio of 7.46 indicates that DOCS has no problem at all paying its short term obligations.
  • DOCS's Current ratio of 7.46 is amongst the best of the industry. DOCS outperforms 88.37% of its industry peers.
  • A Quick Ratio of 7.46 indicates that DOCS has no problem at all paying its short term obligations.
  • DOCS has a better Quick ratio (7.46) than 90.70% of its industry peers.

A Closer Look at Profitability for NYSE:DOCS

ChartMill employs its own Profitability Rating system for stock evaluation. This score, ranging from 0 to 10, is derived from an analysis of diverse profitability metrics and margins. In the case of NYSE:DOCS, the assigned 9 is noteworthy for profitability:

  • DOCS has a Return On Assets of 10.30%. This is amongst the best in the industry. DOCS outperforms 97.67% of its industry peers.
  • DOCS has a Return On Equity of 11.99%. This is amongst the best in the industry. DOCS outperforms 97.67% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 11.05%, DOCS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for DOCS is significantly above the industry average of 3.74%.
  • The last Return On Invested Capital (11.05%) for DOCS is well below the 3 year average (17.24%), which needs to be investigated, but indicates that DOCS had better years and this may not be a problem.
  • DOCS has a Profit Margin of 27.20%. This is amongst the best in the industry. DOCS outperforms 95.35% of its industry peers.
  • DOCS's Profit Margin has improved in the last couple of years.
  • DOCS has a Operating Margin of 30.47%. This is amongst the best in the industry. DOCS outperforms 100.00% of its industry peers.
  • In the last couple of years the Operating Margin of DOCS has grown nicely.
  • DOCS has a better Gross Margin (87.74%) than 95.35% of its industry peers.

Looking at the Setup

In addition to the Technical Rating, ChartMill provides a Setup Rating for each stock. This rating, ranging from 0 to 10, assesses the extent of consolidation in the stock based on multiple short-term technical indicators. Currently, NYSE:DOCS has a 7 as its setup rating:

DOCS has a bad technical rating, but it does show a decent setup pattern. Prices have been consolidating lately and the volatility has been reduced. A pullback is taking place, which may present a nice opportunity for an entry. We notice that large players showed an interest for DOCS in the last couple of days, which is a good sign.

Our Strong Growth screener lists more Strong Growth stocks and is updated daily.

Check the latest full fundamental report of DOCS for a complete fundamental analysis.

Check the latest full technical report of DOCS for a complete technical analysis.

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back

DOXIMITY INC-CLASS A

NYSE:DOCS (2/20/2024, 7:04:00 PM)

After market: 29.72 +0.32 (+1.09%)

29.4

-0.93 (-3.07%)

DOCS News

News Imagean hour ago - The Motley Fool1 Cash-Gushing Stock Down 70% to Buy and Hold Forever

This healthcare upstart, with a free-cash-flow margin of 27% even after removing stock-based compensation, deserves a long look from investors.

News Image2 days ago - ChartmillIs NYSE:DOCS on the Verge of a Major Breakout as a Strong Growth Stock?

DOXIMITY INC-CLASS A (NYSE:DOCS)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.

News Image12 days ago - Market News VideoNotable Friday Option Activity: DOCS, RAMP, HUMA
News Image13 days ago - DoximityDoximity Ranked #1 Best in KLAS Telehealth Video Conferencing Platform for Third Consecutive Year
News Image13 days ago - DoximityDoximity Announces Fiscal 2024 Third Quarter Financial Results
News Image14 days ago - ChartmillIn the world of growth stocks, NYSE:DOCS shines as a value proposition.

Investors seeking growth at a reasonable cost should explore DOXIMITY INC-CLASS A (NYSE:DOCS).

News Image22 days ago - Market News VideoNotable Two Hundred Day Moving Average Cross - DOCS
News Imagea month ago - DoximityDoximity to Release Fiscal 2024 Third Quarter Results on February 8, 2024
News Imagea month ago - InvestorPlace3 Stocks to Capitalize on the Telehealth Explosion

These three telehealth stocks are leading the way for improved telehealth offerings, highlighted after the pandemic.

News Image2 months ago - InvestorPlace7 Stocks that Multiple AI Bots Predict Will Soar in the Near Future

AI chatbots including ChatGPT and Bard believe these stocks are headed higher in the future, perhaps the near future.

News Image2 months ago - Market News VideoBullish Two Hundred Day Moving Average Cross - DOCS
News Image2 months ago - The Motley FoolThe Top Healthcare Stocks to Buy With $100

These stocks haven't been popular with investors lately.

DOCS Links
Follow us for more